CDKN2A (p16; p14ARF) |
HGNC:1787 |
cell cycle arrest/apoptosis/senescence |
hypermethylated |
[5,77,89,98,99,100,101,102,103,104] |
MGMT |
HGNC:7059 |
DNA damage repair |
hypermethylated |
[5,77,89,98,100,101,102,103,104] |
DAPK |
HGNC:2674 |
apoptosis |
hypermethylated |
[5,89,98,100,101,102,103,104] |
APC |
HGNC:583 |
cellular adhesion/migration |
hypermethylated |
[5,77,98,100,101,102] |
RASSF1 |
HGNC:9882 |
cell cycle arrest/ cytoskeleton organization |
hypermethylated |
[5,77,89,101,103,104] |
CDH1 |
HGNC:1748 |
cellular adhesion |
hypermethylated |
[77,100,102,103,104] |
HOXA9 |
HGNC:5109 |
cell differentiation |
hypermethylated |
[91,98,105,106] |
MLH1 |
HGNC:7127 |
DNA damage repair |
hypermethylated |
[5,77,101] |
CDKN2B (p15) |
HGNC:1788 |
cell cycle arrest |
hypermethylated |
[5,77,100,101] |
TIMP3 |
HGNC:11822 |
extracellular matrix degradation |
hypermethylated |
[89,98,103,104] |
ATM |
HGNC:795 |
DNA damage repair |
hypermethylated |
[5,107] |
MINT31 |
N/A |
chromatin remodeling |
hypermethylated |
[89,98,100] |
CALCA |
HGNC:1437 |
cellular metabolism/ inflammatory response |
hypermethylated |
[99,103,106] |
NPY |
HGNC:7955 |
cell proliferation |
hypermethylated |
[105,106] |
HS3ST2 |
HGNC:5195 |
circadian rhythm |
hypermethylated |
[105,106] |
ADGRE3 (EMR3) |
HGNC:23647 |
cellular surface receptor /inflammatory response |
hypomethylated |
[105] |
PI3 |
HGNC:8947 |
inflammatory response |
hypomethylated |
[105] |
AIM2 |
HGNC:357 |
apoptosis/ inflammatory response |
hypomethylated |
[105] |
SPP1 |
HGNC:11255 |
cellular adhesion/ inflammatory response |
hypomethylated |
[105] |